
The merger between Microsoft and Activision is expected to be approved by regulators on May 15, according to sources.
The merger was rejected by UK regulators and Microsoft filed an appeal.
According to Reuters, Microsoft’s acquisition is being approved partly due to their agreement to establish licensing arrangements with competitors in the cloud streaming industry such as Ubitus and Nvidia. The cloud sector played a significant role in the U.K. Competition and Markets Authority’s decision to block the deal, hence it is uncertain whether Microsoft’s ongoing efforts to secure licensing deals and other forms of cloud cooperation will be sufficient to succeed in appealing to the CMA.
Read more: Sony Calls UK’s Reversed Stance On Microsoft Activision Deal ‘Surprising & Irrational’
According to a European Commission spokesperson, Reuters’ reporting on the ongoing investigation cannot be confirmed at this time. The Commission has until May 22, 2023 to make a decision.
Activision Blizzard King chose not to comment, and Microsoft has not yet responded to a comment request.
If the acquisition effort of $69 billion is successful, Microsoft will gain control of significant gaming franchises like “Call of Duty” and “Diablo,” following the acquisition of ZeniMax and their well-known properties like “The Elder Scrolls” and “Fallout.”
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas